B-type natriuretic peptide vs. cardiac risk scores for prediction of outcome following major orthopedic surgery

Journal of Cardiovascular Medicine

Volumn 16, Issue 6, 2015, Pages 465-471

  Katsanos, Spyridon ^a   Babalis, Dimitrios ^a   Kafkas, Nikolaos ^a   Mavrogenis, Andreas ^b   Leong, Darryl ^c   Parissis, John ^b   Varounis, Christos ^b   Makris, Konstantinos ^d   Van Der Heijden, Aafke ^e   Anastasiou Nana, Maria ^b   Filippatos, Gerasimos ^b  

^a KAT General Hospital   (Greece)

^b Istituto di Radiologia   (Greece)

^c FLINDERS UNIVERSITY   (Australia)

^d KAT HOSPITAL   (Greece)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B type natriuretic peptide; orthopedic; risk score

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; LEVOBUPIVACAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; ROPIVACAINE; BIOLOGICAL MARKER;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; FEMALE; GENERAL ANESTHESIA; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORTHOPEDIC SURGERY; POSTOPERATIVE PAIN; PREDICTION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASES; FOLLOW UP; PREOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

AGED; AGED, 80 AND OVER; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; ORTHOPEDIC PROCEDURES; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84929029024     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000210     Document Type: Article

References (31)

1. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008; 10:824-839.
2. Karthikeyan G, Moncur RA, Levine O, et al. Is a preoperative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009; 54:1599-1606.
3. Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of preoperative and postoperative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol 2014; 63: 170-180.
4. Vetrugno L, Langiano N, Gisonni R, et al. Prediction of early postoperative major cardiac events after elective orthopedic surgery: the role of B-type natriuretic peptide, the revised cardiac risk index, and ASA class. BMC Anesthesiol 2014; 14:20.
5. Oscarsson A, Fredrikson M, Sö rliden M, Anskä r S, Eintrei C. N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery. Br J Anaesth 2009; 103:206-212.
6. Park JH, Shin GJ, Ryu JI, Pyun WB. Postoperative B-type natriuretic peptide levels associated with prolonged hospitalization in hypertensive patients after noncardiac surgery. Korean Circ J 2012; 42:521-527.
7. Rodseth RN, Lurati Buse GA, Bolliger D, et al. The predictive ability of preoperative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis. J Am Coll Cardiol 2011; 58:522-529.
8. Rodseth RN, Biccard BM, Chu R, et al. Postoperative B-type Natriuretic Peptide for Prediction of Major Cardiac Events in Patients Undergoing Noncardiac Surgery: Systematic Review and Individual Patient Metaanalysis. Anesthesiology 2013; 119:270-283.
9. Farzi S, Stojakovic T, Marko T, et al. Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent noncardiac surgery. Br J Anaesth 2013; 110:554-560.
10. Chong CP, Ryan JE, van Gaal WJ, et al. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. Am J Cardiol 2010; 106:865-872.
11. Breidthardt T, Kindler CH, Schindler C, et al. B-type natriuretic peptide in patients undergoing orthopaedic surgery: a prospective cohort study. Eur J Anaesthesiol 2010; 27:690-695.
12. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery. Eur Heart J 2009; 30:2769-2812.
13. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:1971-1996.
14. Poldermans D, Hoeks SE, Feringa HH. Preoperative risk assessment and risk reduction before surgery. J Am Coll Cardiol 2008; 51:1913-1924.
15. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845-850.
16. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
17. Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 1986; 146:2131-2134.
18. Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001; 345:1677-1682.
19. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007; 116:2634-2653.
20. Redfern G, Rodseth RN, Biccard BM. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta-analysis. Anaesthesia 2011; 66:604-610.
21. Dawson-Bowling S, Chettiar K, Cottam H, et al. Troponin T as a predictive marker of morbidity in patients with fractured neck of femur. Injury 2008; 39:775-780.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845.
23. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172.
24. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372:139-144.
25. Devereaux PJ, Ghali WA, Gibson NE, et al. Physician estimates of perioperative cardiac risk in patients undergoing noncardiac surgery. Arch Intern Med 1999; 159:713-717.
26. Burgos E, Gómez-Arnau JI, Déz R, Munõz L, Fernández-Guisasola J, Garcia del Valle S. Predictive value of six risk scores for outcome after surgical repair of hip fracture in elderly patients. Acta Anaesthesiol Scand 2008; 52:125-131.
27. Omland T, Sabatine MS, Jablonski KA, et al., PEACE Investigators. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 2007; 50:205-214.
28. Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003; 107:1884-1890.
29. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005; 45:82-86.
30. Turner KL, Moore LJ, Todd SR, et al. Identification of cardiac dysfunction in sepsis with B-type natriuretic peptide. J Am Coll Surg 2011; 213:139-146.
31. Lin WP, Wen CJ, Jiang CC, Chen CY, Lin J. Risk factors for hip fracture sites and mortality in older adults. J Trauma 2011; 71:191-197.